Sarepta says the patient’s death in the FDA database.

Photo of author

By [email protected]


https://www.tipranks.com/news/the-fly/sarepta-could-be-dn-on-patience

RBC Capital Analyst Brian Abrahams said, Sahart Saharaba.SRPTIt can be traded to some extent today on the update of the FDA database, which included the death of the patient’s AM elevidys, which occurred in November in a patient who suffered from muscle spasms.

First published on Thefly -The final source of the actual time, the financial financial news in the market. Try now >>

See hot stocks for those familiar with Tipranks >>

Read more about SRPT:



https://media.zenfs.com/en/tipranks_452/bbad1dd12cc6ba90ddd83aeee03f1aae

Source link

Leave a Comment